Le Roux H A, Urry R J, Sartorius B, Aldous C
Department of Urology, Greys Hospital, Pietermaritzburg, South Africa, School of Clinical Medicine, University of KwaZulu-Natal, South Africa.
School of Nursing and Public Health, University of KwaZulu-Natal, South Africa.
S Afr J Surg. 2015 Dec;53(3 and 4):57-62.
The objectives were to document the presentation of prostate cancer in the Zulu population of KwaZulu-Natal in South Africa, to identify this as a high-risk population, and to determine the potential for under-diagnosis in this population.
All histopathology results confirming prostatic adenocarcinoma from biopsies preformed at Edendale hospital from 01/11/2012 to 30/04/2014 were collected. A total of 81 participants were enrolled, and a review of their outpatient records was performed. Patient presentation was analysed, younger patients were compared to older patients, and observed incidence was compared to expected incidence.
The majority of patients (66%, 95% confidence interval [CI]:54-76%) presented with radiographic evidence of metastatic disease or PSA greater than 100 ng/ml. The median PSA level at presentation was 154 ng/ml (Interquartile range [IQR] = 39-448). Clinically staged T4 disease was present in 44% of patients and only 10% of patients presented with PSA detected disease. Poorly differentiated tumours (Gleason grades 8, 9 and 10) were found in 43% of patients. Only 81 out of a maximum potential of 625 incident prostate cancer cases were diagnosed.
Black South African men from a predominantly rural Zulu population present late and with advanced and aggressive disease. We are missing the opportunity for remission in most patients in this high risk population group. The establishment of a National Prostate Cancer Registry and further research into a prostate cancer screening programme may be beneficial to this community.
本研究旨在记录南非夸祖鲁 - 纳塔尔省祖鲁族人群中前列腺癌的表现,确定该人群为高危人群,并确定该人群中前列腺癌漏诊的可能性。
收集2012年11月1日至2014年4月30日期间在伊登代尔医院进行活检确诊为前列腺腺癌的所有组织病理学结果。共纳入81名参与者,并对其门诊记录进行回顾。分析患者的临床表现,比较年轻患者与老年患者,并将观察到的发病率与预期发病率进行比较。
大多数患者(66%,95%置信区间[CI]:54 - 76%)出现转移性疾病的影像学证据或PSA大于100 ng/ml。就诊时PSA的中位数水平为154 ng/ml(四分位间距[IQR]=39 - 448)。44%的患者临床分期为T4期疾病,仅10%的患者因PSA检测出疾病。43%的患者发现低分化肿瘤(Gleason分级8、9和10级)。在最多可能的625例前列腺癌新发病例中,仅诊断出81例。
来自以农村为主的祖鲁族人群的南非黑人男性就诊时病情较晚,患有晚期侵袭性疾病。在这个高危人群组中,我们错失了大多数患者缓解病情的机会。建立国家前列腺癌登记处并进一步研究前列腺癌筛查项目可能对该社区有益。